Animal rights group urges SEC to investigate Charles River over monkey purchases; Cancer vaccine startup launches with $54 million, Spark veteran as CEO

Taking stock of the drug industry, from the lab to the medicine chest

April 18, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Wong Maye-E/AP STAT+ | Animal rights group urges SEC to investigate Charles River over monkey purchases "The company's shareholders... have the right to expect that their company won't mislead them with deceptive statements," PETA maintained. By Ed Silverman STAT+ | Cancer vaccine startup launches with $54 million, Spark veteran as CEO Corner Therapeutics' Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff. By Allison DeAngelis STAT+ | Cerevel drug for Parkinson's disease improved symptom control in trial The neuroscience biotech that AbbVie is acquiring said Thursday its drug tavapadon, taken with the drug levodopa, showed positive results. By Elaine Chen Adobe STAT+ | ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs So far, Metsera's obesity drug pipeline includes a drug targeting the GLP-1 hormone receptor and another that spurs a hormone called amylin. By Allison DeAngelis STAT+ | 23andme CEO Anne Wojcicki moves to take company private CEO Anne Wojcicki disclosed her plans in a filing with the Securities and Exchange Commission late Wednesday. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser